Mainz, Germany

Jan Schultess

This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 2015.


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Jan Schultess

Introduction

Jan Schultess is a distinguished inventor based in Mainz, Germany. He has made significant contributions to the field of vitamin D research, holding a notable patent that addresses the complexities of vitamin D binding proteins.

Latest Patents

Jan is the inventor of a patent titled, “Truncated human vitamin D binding protein and mutation and fusion thereof and related materials and methods of use.” This patent focuses on vitamin D binding proteins (DBP), particularly truncated DBP and mutated, truncated DBP, as well as fusion proteins. The invention encompasses nucleic acid molecules that encode these proteins, along with vectors, host cells, and methodologies for determining the total amount of 25-hydroxy vitamin D in a test sample, which has vital implications in health diagnostics.

Career Highlights

Jan Schultess is associated with Abbott Laboratories Corporation, a reputable organization known for its health care innovations and research contributions. His work in developing a patented method for analyzing vitamin D levels showcases his commitment to advancing medical science.

Collaborations

Throughout his career, Jan has collaborated with notable colleagues such as Christian Beckert and Susan E Brophy. These collaborations have enhanced the scope of his research and its applications in the medical field.

Conclusion

Jan Schultess’s innovative work in vitamin D binding proteins exemplifies the importance of research and development in enhancing health diagnostics. His patent not only reflects his expertise but also the collaborative effort required to drive significant advancements in science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…